{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:56:55Z","timestamp":1777262215002,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Buryk Foundation","award":["not applicable"],"award-info":[{"award-number":["not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As part of a late onset GM2 gangliosidosis natural history study, digital health technology was utilized to monitor a group of patients remotely between hospital visits. This approach was explored as a means of capturing continuous data and moving away from focusing only on episodic data captured in traditional study designs. A strong emphasis was placed on real-time capture of symptoms and mobile Patient Reported Outcomes (mPROs) to identify the disease impact important to the patients themselves; an impact that may not always correlate with the measured clinical outcomes assessed during patient visits. This was supported by passive, continuous data capture from a wearable device.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Adherence rate for wearing the device and completing the mPROs was 84 and 91%, respectively, resulting in a rich multidimensional dataset. As expected for a six-month proof-of-concept study in a disease that progresses slowly, statistically significant changes were not expected or observed in the clinical, mPROs, or wearable device data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study demonstrated that patients were very enthusiastic and motivated to engage with the technology as demonstrated by excellent compliance. The combination of mPROs and wearables generates feature-rich datasets that could be a useful and feasible way to capture remote, real-time insight into disease burden.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01473-x","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T21:02:30Z","timestamp":1596488550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)"],"prefix":"10.1186","volume":"15","author":[{"given":"Elin Haf","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Toro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia J.","family":"Tifft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"1473_CR1","doi-asserted-by":"crossref","unstructured":"Lew R, Burnett L, Delatycki M, Proos A. Tay-Sachs disease: current perspectives from Australia. Appl. Clin. Genet. 2015;8:19.","DOI":"10.2147\/TACG.S49628"},{"issue":"4","key":"1473_CR2","first-page":"817","volume":"46","author":"R Navon","year":"1990","unstructured":"Navon R, Kolodny EH, Mitsumoto H, Thomas GH, Proia RL. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect. Am J Hum Genet. 1990;46(4):817\u201321.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1473_CR3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/mus.24146","volume":"49","author":"A Deik","year":"2014","unstructured":"Deik A, Saunders-Pullman R. Atypical Presentation of Late-Onset Tay-Sachs Disease. Muscle Nerve. 2014;49(5):768\u201371.","journal-title":"Muscle Nerve"},{"issue":"1","key":"1473_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13023-015-0260-7","volume":"10","author":"E Osher","year":"2015","unstructured":"Osher E, et al. Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot study. Orphanet J. Rare Dis. 2015;10(1):45.","journal-title":"Orphanet J. Rare Dis"},{"key":"1473_CR5","doi-asserted-by":"crossref","unstructured":"Solovyeva VV, et al. New Approaches to Tay-Sachs Disease Therapy. Front Physiol. 2018;9:1\u201311. https:\/\/pubmed.ncbi.nlm.nih.gov\/30524313\/.","DOI":"10.3389\/fphys.2018.01663"},{"issue":"1","key":"1473_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1056\/NEJMp1702978","volume":"377","author":"JF Baumhauer","year":"2017","unstructured":"Baumhauer JF. Patient-reported outcomes \u2014 are they living up to their potential? N Engl J Med. 2017;377(1):6\u20139.","journal-title":"N Engl J Med"},{"issue":"0","key":"1473_CR7","first-page":"253","volume":"245","author":"J Wang","year":"2017","unstructured":"Wang J, et al. Development of a smartphone application to monitor pediatric patient-reported outcomes. Stud Health Technol Inform. 2017;245(0):253\u20137.","journal-title":"Stud Health Technol Inform"},{"key":"1473_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cct.2017.11.002","volume":"64","author":"G Gresham","year":"2018","unstructured":"Gresham G, et al. Wearable activity monitors in oncology trials : Current use of an emerging technology. Contemp. Clin. Trials. 2018;64:13\u201321.","journal-title":"Contemp. Clin. Trials"},{"issue":"6","key":"1473_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/WCO.0000000000000026","volume":"26","author":"BH Dobkin","year":"2013","unstructured":"Dobkin BH. Wearable motion sensors to continuously measure real-world physical activities. Curr Opin Neurol. 2013;26(6):602\u20138.","journal-title":"Curr Opin Neurol"},{"key":"1473_CR10","doi-asserted-by":"crossref","unstructured":"Sinclair SJ, Blais MA, Gansler DA, Sandberg E, Bistis K, LoCicero A. Psychometric properties of the Rosenberg elf-esteem scale: overall and across demographic groups living within the United States. Eval Heal Prof. 2010;33(1):56\u201380.","DOI":"10.1177\/0163278709356187"},{"issue":"10","key":"1473_CR11","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s11136-014-0734-4","volume":"23","author":"L Haverman","year":"2014","unstructured":"Haverman L, Limperg PF, van Oers HA, van Rossum MAJ, Maurice-Stam H, Grootenhuis MA. Psychometric properties and Dutch norm data of the PedsQL multidimensional fatigue scale for young adults. Qual Life Res. 2014;23(10):2841\u20137.","journal-title":"Qual Life Res"},{"key":"1473_CR12","doi-asserted-by":"crossref","unstructured":"Tudor-Locke C, et al. How many steps\/day are enough? for adults. Int J Behav Nutr Phys Act. 2011;8(79):2-19.","DOI":"10.1186\/1479-5868-8-79"},{"key":"1473_CR13","doi-asserted-by":"crossref","unstructured":"Hollander M, Wolfe DA, Chicken E. Nonparametric statistical methods. London: Wiley; 2015. https:\/\/www.wiley.com\/en-gb\/Nonparametric+Statistical+Methods%2C+3rd+Edition-p-9780470387375.","DOI":"10.1002\/9781119196037"},{"issue":"3","key":"1473_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H. User\u2019s guide to correlation coefficients. Turk J Emerg Med. 2018;18(3):91\u20133.","journal-title":"Turk J Emerg Med"},{"issue":"1","key":"1473_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13023-015-0240-y","volume":"10","author":"S Fecarotta","year":"2015","unstructured":"Fecarotta S, et al. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C. Orphanet J. Rare Dis. 2015;10(1):22.","journal-title":"Orphanet J. Rare Dis"},{"issue":"4","key":"1473_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A Global Measure of Perceived Stress. J. Health Soc. Behav. 1983;24(4):385.","journal-title":"J. Health Soc. Behav"},{"key":"1473_CR17","volume-title":"Assessing outcomes in child and youth programs: a practical handbook revised edition","author":"RM Sabatelli","year":"2005","unstructured":"Sabatelli RM, Anderson SA. Assessing outcomes in child and youth programs: a practical handbook revised edition. Connect: US Dep. Justice to State Connect; 2005."},{"key":"1473_CR18","unstructured":"Rosenberg M. Society and the adolescent self-image: Princeton university press; 2015."},{"issue":"1","key":"1473_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12955-015-0218-4","volume":"13","author":"G Furber","year":"2015","unstructured":"Furber G, Segal L. The validity of the Child Health Utility instrument (CHU9D) as a routine outcome measure for use in child and adolescent mental health services. Health Qual. Life Outcomes. 2015;13(1):22.","journal-title":"Health Qual. Life Outcomes"},{"issue":"1","key":"1473_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11136-012-0119-5","volume":"22","author":"AG Canaway","year":"2013","unstructured":"Canaway AG, Frew EJ. Measuring preference-based quality of life in children aged 6\u20137 years: a comparison of the performance of the CHU-9D and EQ-5D-Y\u2014the WAVES pilot study. Qual Life Res. 2013;22(1):173\u201383.","journal-title":"Qual Life Res"},{"issue":"12","key":"1473_CR21","first-page":"2494","volume":"31","author":"JW Varni","year":"2004","unstructured":"Varni JW, Burwinkle TM, Szer IS. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J. Rheumatol. 2004;31(12):2494\u2013500.","journal-title":"J. Rheumatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01473-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:29Z","timestamp":1627948829000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01473-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1473"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01473-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave informed consent, and the study was approved by the National Human Genome Research Institute Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests other than ED is an employee of Aparito.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"199"}}